Navigation Links
Gentamicin in Medical News

Innocoll Agrees the Sale of its CollaRx(R) GENTAMICIN SURGICAL IMPLANT and European Sales and Marketing Infrastructure to EUSA Pharma

ASHBURN, Va., Sept. 6 /PRNewswire/ -- Innocoll, Inc. announced that it has agreed the sale of its CollaRx(R) GENTAMICIN SURGICAL IMPLANT and European sales and marketing infrastructure to EUSA Pharma Inc., a transatlantic specialty pharmaceutical company focused on oncology, pain control and c...

BUSM researchers find gram-negative rods in two Philippine neonatal intensive care units

...n standard infection control measures. Over a 10-month period, BUSM researchers conducted studies for colonization and bloodstream infections with gentamicin or third generation cephalosporin-resistant GNR among all NICU infants weekly and then on the day of discharge. Researchers found a total of 1,997 res...

Physicians ask EPA, 'Antibiotics to cure sick apples, or sick children?'

... Michigan to spray the state's apple orchards with gentamicin risks undermining the value of this important anti...he state of Michigan "emergency" permission to use gentamicin to fight a tree disease called fire blight. "At...pples," said IDSA President Donald Poretz, MD. gentamicin is a crucial antibiotic used to treat dangerous ga...

AlphaRx Signs Cooperative Research and Development Agreement with US Army

...ed mainly in biological weapons that pose a risk to national security. The MTA covers several "nanobiotics" including Ciprofloxacin, Doxycycline and gentamicin developed by AlphaRx. These are the usual antibiotics used to treat patients in a bioterrorism event. However, they all show limited efficacy clinical...

Innocoll Receives 'Intends to Grant' Notices from the European Patent Office for Two European Patent Applications Related to Novel Wound Healing, Biosurgery and Drug Delivery Applications of its CollaRx(R) Technology

...nology forms the basis of Innocoll's lead product, gentamicin Surgical Implant, a biodegradable leave-behind imp...ost-operative pain and a topically-applied CollaRx gentamicin Sponge for the treatment and prevention of diabeti...aRx(R) and Liquicoll(R). Innocoll 's lead product, gentamicin Surgical Implant for the treatment and prevention ...

Bacteriophages may Boost the Effectiveness of Antibiotics

...spital-acquired infections. Experiments in mice revealed that 75% of those infected with a lethal dose of Pseudomonas survived if the antibiotic gentamicin was administered in the presence of bacteriophages. None survived without the phages (Microb. Drug Resist., 2006, 12 (3), 164). The bacteriophag...

Red Wine May Reduce The Risk Of Age Related Deafness

...atients' ears caused by the antibiotic gentamicin. gentamicin they explained is often used to treat severe, acut...ss had affected just 3% of patients who were given gentamicin plus aspirin for acute ear infections compared with 13% treated with gentamicin plus a placebo. Jochen Schacht while present...
Gentamicin in Medical Technology

Innocoll Announces Dosing of Last Patient in Second US Phase 3 Clinical Trial to Investigate GENTAMICIN SURGICAL IMPLANT for Prevention of Surgical Site Infections in Colorectal Surgery Patients

ASHBURN, Va., March 19 /PRNewswire/ -- Innocoll, Inc., a privately-held biopharmaceutical company, announced that the last patient has been dosed in the second of two ongoing U.S. phase 3 clinical trials sponsored by its wholly owned subsidiary, Innocoll Technologies Ltd, to investigate CollaRx(R)...

Innocoll Announces Dosing of Last Patient in US Phase 3 Clinical Trial to Investigate GENTAMICIN SURGICAL IMPLANT for Prevention of Surgical Site Infections in Cardiac Surgery Patients

ASHBURN, Va., March 16 /PRNewswire/ -- Innocoll, Inc., a privately-held biopharmaceutical company, announced that the last patient has been dosed in the first of two ongoing U.S. phase 3 clinical trials sponsored by its wholly owned subsidiary, Innocoll Technologies Ltd, to investigate CollaRx(R) ...

Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) GENTAMICIN TOPICAL for the Prevention of Diabetic Foot Infections

ASHBURN, Va., April 30 /PRNewswire/ -- Innocoll, Inc., a privately-held biopharmaceutical company, announced that the last of three planned phase 2 clinical trials sponsored by its wholly owned subsidiary, Innocoll Technologies Ltd, to investigate CollaRx(R) GENTAMICIN TOPICAL for the treatmen...

Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) GENTAMICIN TOPICAL for the Treatment of Moderately Infected Diabetic Foot Ulcers

ASHBURN, Va., April 17 /PRNewswire/ -- Innocoll, Inc., a privately-held biopharmaceutical company, announced that the second of three planned phase 2 clinical trials sponsored by its wholly owned subsidiary, Innocoll Technologies Ltd, to investigate CollaRx(R) GENTAMICIN TOPICAL for the treatm...

Innocoll Announces Dosing of First Patient in Second US Phase 3 Clinical Trial to Investigate CollaRx(R) GENTAMICIN SURGICAL IMPLANT for the Prevention of Surgical Site Infections

ASHBURN, Va., Feb. 19 /PRNewswire/ -- Innocoll, Inc., a privately-held specialty pharmaceutical company, announced that the second of two phase 3 clinical trials sponsored by its wholly owned subsidiary, Innocoll Technologies Ltd, to investigate CollaRx(R) GENTAMICIN SURGICAL IMPLANT for the p...

Innocoll Announces Dosing of First Patient in US Phase 3 Clinical Trial to Investigate CollaRx(R) GENTAMICIN SURGICAL IMPLANT for the Prevention of Surgical Site Infections in Cardiac Surgery Patients

ASHBURN, Va., Jan. 2 /PRNewswire/ -- Innocoll, Inc., a privately-held specialty pharmaceutical company, announced that the first of two phase 3 clinical trials sponsored by its wholly owned subsidiary, Innocoll Technologies Ltd, to investigate CollaRx(R) GENTAMICIN SURGICAL IMPLANT for the pre...

Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) GENTAMICIN TOPICAL for the Treatment of Mildly Infected Diabetic Foot Ulcers

ASHBURN, Va., Dec. 18 /PRNewswire/ -- Innocoll, Inc., a privately-held specialty pharmaceutical company, announced that the first of three planned phase 2 clinical trials sponsored by its wholly owned subsidiary, Innocoll Technologies Ltd, to investigate CollaRx(R) GENTAMICIN TOPICAL for the t...

Innocoll Announces Dosing of Last Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) BUPIVACAINE SURGICAL IMPLANT for the Management of Post-Operative Pain

...aRx(R) and Liquicoll(R). Innocoll 's lead product, gentamicin Surgical Implant for the treatment and prevention ...ghts with the exception of the US, to EUSA Pharma. gentamicin Surgical Implant is currently in phase 3 developme...in Innocoll's development pipeline include CollaRx gentamicin Topical for the treatment and prevention of infect...

CAPHOSOL(R) Relieves Oral Mucositis (OM) and Improves Quality-of-Life in Cancer Patients Receiving Chemoradiation

...thetic patch which recently received Europe-wide approval. EUSA also has several products in late-stage development, notably Collatamp(R) G topical, a gentamicin impregnated collagen sponge for the prevention and treatment of infected skin ulcers, and CollaRx(R) bupivacaine implant* for local post-surgical pain...

Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) BUPIVACAINE SURGICAL IMPLANT for the Management of Post-operative Pain

... pharmaceutical products and medical devices using its proprietary collagen-based technologies, CollaRx(R) and Liquicoll(R). Innocoll 's lead product, gentamicin SURGICAL IMPLANT, for the treatment and prevention of surgical site infections, is approved for sale in 49 countries in Europe, Latin America, Middle ...
Gentamicin in Medical Products

Depuy 1 Gentamicin Bone Cement

Description: DePuy 1 Gentamicin Bone Cement, a high viscosity antibiotic bone cement, clinically proven in the international market for over a decade, eliminates the inconvenience of mixing an antibiotic into cement. The premixed powder helps to prevent inconsistency in cement-handling characteristics. DePuy 1 ...
Company:DePuy Orthopaedics, Inc.

Gibco Gentamicin Reagent Solution (50 mg/ml) liquid

Description: Gentamicin is a selection antibiotic used for selection of a Bac-to-Bac recombinant expression bacmid following transposition. Gentamicin is provided as a solution at a concentration of 50 mg/ml....
Company:Invitrogen

Gibco Gentamicin Reagent Solution (50 mg/ml), liquid

Description: Contains 50 mg/ml gentamicin sulfate in distilled water....
Company:Invitrogen

Gibco Gentamicin Reagent Solution (10 mg/ml) liquid

Description: Gentamicin Reagent Solution (10 mg/ml) liquid...
Company:Invitrogen

Palacos® G Bone Cement with Gentamicin

Description: For over 35 years, Palacos® Bone Cement has clinically proven itself as the gold standard in cemented arthroplasty. Palacos® is now available with the addition of gentamicin, providing an antibiotic loaded bone cement cleared for use in the second stage of a two-stage revision after infecti...
Company:Biomet Orthopedics, Inc

CEMEX Genta

Description:... Bone cement with gentamicin 2.5%....
Company:Exactech, Inc.

Gentamicin

Description:... gentamicin is an aminoglycosidic antibiotic that inhibits bacterial growth by inhibiting protein synthesis. gentamicin is used for prevention and elimination of bacterial contaminants in cell cu...
Company:Roche Applied Science

GENTAFIX 3

Features:...r) Rapid setting time Rapid final hardening Excellent mechanical properties that are above the ISO 5833 requirements Rapid release of the gentamicin (GENTAFIX 1 & 3) Optimal polymerisation kinetics ...
Company:Mathys AG

CEMFIX 3

Features:...r) Rapid setting time Rapid final hardening Excellent mechanical properties that are above the ISO 5833 requirements Rapid release of the gentamicin (GENTAFIX 1 & 3) Optimal polymerisation kinetics ...
Company:Mathys AG

GENTAFIX 1

Features:...r) Rapid setting time Rapid final hardening Excellent mechanical properties that are above the ISO 5833 requirements Rapid release of the gentamicin (GENTAFIX 1 & 3) Optimal polymerisation kinetics ...
Company:Mathys AG

More>>

Gentamicin in Biological News

Milk may help bacteria survive against low levels of antibiotics

...t milk may also protect bacteria against low concentrations of antibiotics in the presence of milk, three of the five antibiotics tested, penicillin, gentamicin and sulphamethoxazole combined with trimethoprim, were less effective against Staphylococcus when compared with the same experiment performed in the a...

Poultry workers at increased risk of carrying antibiotic-resistant E. coli

...or resistance to the antimicrobials ampicillin, ciprofloxacin, ceftriazone, gentamicin and tetracycline. Findings showed that poultry workers had 32 times greater...nt antimicrobial drugs are approved for use in U.S. poultry production with gentamicin reported to be the most widely used. ...

Clues to gene expression in cystic fibrosis will guide research

...rare genetic stop mutation responded positively to gentamicin treatment. Aleksander Edelman and Isabelle Serme...al French institutions studying how the antibiotic gentamicin affected CF patients with a stop mutation. The tea...nly in inhabitants of Reunion island, responded to gentamicin treatment. Cystic fibrosis is caused by mutat...

New approach could lower antibiotic requirements by 50 times

...hospital-acquired infections. Experiments in mice revealed that 75% of those infected with a lethal dose of Pseudomonas survived if the antibiotic gentamicin was administered in the presence of bacteriophages. None survived without the phages (Microb. Drug Resist., 2006, 12 (3), 164). The bacteriophage ...
Gentamicin in Biological Technology

Innocoll Announces Provisional Findings From Its Three Phase 2 Clinical Trials Investigating CollaRx(R) GENTAMICIN TOPICAL for the Treatment and Prevention of Diabetic Foot Infections

ASHBURN, Va., June 18 /PRNewswire/ -- Innocoll, Inc., a privately-held biopharmaceutical company, announced positive provisional findings from its three phase 2 clinical trials sponsored by its wholly owned subsidiary, Innocoll Technologies Ltd, to investigate CollaRx(R) GENTAMICIN TOPICAL for the...

Baxter Announces Licensing Agreement for Innocoll's Gentamicin Surgical Implant in the United States

The antibiotic surgical product may reduce incidence of surgical site infections and reduce post-operative cost and complications DEERFIELD, Ill. and ASHBURN, Va., Aug. 25 /PRNewswire-FirstCall/ -- Baxter Healthcare Corporation today announced a licensing agreement with Innocoll Pharmace...

Innocoll, Inc. Files 510 (k) Application for CollaRx Lidocaine Sponge

...e basis of Innocoll Pharmaceuticals' lead product, gentamicin Surgical Implant, a biodegradable leave-behind imp...s US marketing rights to its lead product, CollaRx gentamicin SURGICAL IMPLANT to a division of Baxter Internati...in Innocoll's development pipeline include CollaRx gentamicin Topical for the treatment and prevention of infect...

Innocoll Appoints Anthony H. Wild Ph.D. to Its Board of Directors

...aRx(R) and Liquicoll(R). Innocoll 's lead product, gentamicin Surgical Implant for the treatment and prevention ...hts, with the exception of the US, to EUSA Pharma. gentamicin Surgical Implant is currently in phase 3 developme...in Innocoll's development pipeline include CollaRx gentamicin Topical for the treatment and prevention of infect...

Innocoll Announces Dosing of First Patient in a Second US Phase 2 Clinical Trial to Investigate CollaRx(R) BUPIVACAINE SURGICAL IMPLANT for the Management of Post-operative Pain

...treatment of infected diabetic foot ulcers and our gentamicin Surgical Implant for the prevention of surgical si...aRx(R) and Liquicoll(R). Innocoll 's lead product, gentamicin Surgical Implant for the treatment and prevention ...hts, with the exception of the US, to EUSA Pharma. gentamicin Surgical Implant is currently in phase 3 developme...

ZARS Pharma Announces Marketing Authorization of Rapydan(R) in Europe

... leukemia, and Rapydan(R), a rapid-onset anesthetic patch. EUSA also has several products in late-stage development, notably Collatamp(R) G topical, a gentamicin impregnated collagen sponge for the prevention and treatment of infected skin ulcers, and CollaRx(R) bupivacaine implant for local post-surgical pain ...

Innocoll Announces Closing of $30 Million Equity Financing Investment

...rmany and South Africa. Innocoll's lead product, gentamicin SURGICAL IMPLANT, is a fully biodegradable, leave-...gned to provide a high localized concentrations of gentamicin at the target tissue. The product is indicated as ...s, with the exception of the U.S., to EUSA Pharma. gentamicin SURGICAL IMPLANT is currently in phase 3 clinical ...

Immunoassay of Theophylline by fluorescence polarisation

... >

Finally, a trial sample was produced which contained the following concentrations of eleven different drugs: gentamicin at 5 g/mL theophylline at 17.8 g/mL tobramycin at 6.5 g/mL quinidine at 2.6 g/mL phenytoin at 12 g/mL ...

High-content screening of GPCR activation with MetaXpress, AcuityXpress and the Transfluor assay system

...ll microplates (Cat. #3712) U2OS media: MEM (Gibco Cat. #11095) with 10% heat-inactivated FCS (Gibco Cat. #10082), 10 g/mL gentamicin (Gibco Cat. #15710), 10 mM HEPES (Gibco Cat. #11344), 0.4 mg/mL Zeocin (Gibco Cat. #R250) and 0.4 mg/mL G418 (Gibco Cat. #10131)...
Gentamicin in Biological Definition

Antibiotic

...re are many way to classify antibiotics. One such classification is by chemical structure: Aminoglycosides Amikacin Dibekacin gentamicin Kanamycin Neomycin Netilmicin Paromomycin Sisomycin Streptomycin Tobramycin Beta-lactam ring antibiotics...
Other Tags
(Date:12/22/2014)... LENEXA, Kan. (PRWEB) December 22, 2014 ... it will add a subscription option to their ad ... for report writing services. Customers can sign up for ... report writing hours each month at a deeply discounted ... pricing tiers, and each has a progressively discounted rate. ...
(Date:12/22/2014)... December 22, 2014 On December 22, ... by Pastor Gordon Cashwell for an episode to celebrate ... Gordon, “Why is it so important to you that ... Cashwell replies, “We all should respect who Jesus was. ... founded on Christian beliefs. That means that on Jesus’ ...
(Date:12/22/2014)... Harrisburg, NC (PRWEB) December 22, 2014 ... contain the current Ebola virus epidemic are ... by U.S. government agencies, nongovernmental organizations (NGOs) ... solutions remains ongoing, healthcare workers, emergency responders, ... advanced technologies such as the CmTP ...
(Date:12/22/2014)... -- A new vaccine created to fight an illness ... protect livestock and even humans from similar brain infections, ... deer from becoming infected by the incurable brain disorder ... in the Dec. 21 online edition of the journal ... mysterious infectious particles known as prions that go rogue. ...
(Date:12/22/2014)... 22, 2014 The Bob Woodruff ... having invested more than $5 million in programs ... and their families. , This includes $1.3 million ... nonprofits, helping with: veteran entrepreneurship; community impact; vocational ... for severely injured veterans. , “The needs of ...
Breaking Medicine News(10 mins):Health News:Sagacious Consultants’ New Subscription Packages Offer Customers Additional Report Writing Options 2Health News:Sagacious Consultants’ New Subscription Packages Offer Customers Additional Report Writing Options 3Health News:My Positive Perspective Celebrates Christmas With an Event to Celebrate the Birthday of Jesus 2Health News:Novel Biostatic Antimicrobial Technology From Clearstream-mPact Technology Partnership (CmTP) Offers Effective Protection Against Transmission of Ebola Virus 2Health News:Novel Biostatic Antimicrobial Technology From Clearstream-mPact Technology Partnership (CmTP) Offers Effective Protection Against Transmission of Ebola Virus 3Health News:Novel Biostatic Antimicrobial Technology From Clearstream-mPact Technology Partnership (CmTP) Offers Effective Protection Against Transmission of Ebola Virus 4Health News:Novel Biostatic Antimicrobial Technology From Clearstream-mPact Technology Partnership (CmTP) Offers Effective Protection Against Transmission of Ebola Virus 5Health News:Vaccine for Deer Against 'Mad Cow'-Like Illness Shows Promise 2Health News:Bob Woodruff Foundation Poised to Reach More Vets Thanks to Banner Year 2Health News:Bob Woodruff Foundation Poised to Reach More Vets Thanks to Banner Year 3Health News:Bob Woodruff Foundation Poised to Reach More Vets Thanks to Banner Year 4Health News:Bob Woodruff Foundation Poised to Reach More Vets Thanks to Banner Year 5Health News:Bob Woodruff Foundation Poised to Reach More Vets Thanks to Banner Year 6Health News:Bob Woodruff Foundation Poised to Reach More Vets Thanks to Banner Year 7
(Date:12/11/2014)... 2014  Data Sciences International (DSI), the global ... new series of digital telemetry implants to meet ... series, part of the PhysioTel™ Digital platform, was ... physiologic data when incorporating functional endpoints into repeat-dose ... toxicology studies has evolved from short ECG strips ...
(Date:12/10/2014)... 9, 2014  Valencell, a leader in performance biometric ... staggering demand from its licensees for highly accurate, clinically ... not solely coming from fitness and health sectors, but ... "A wearable is only as useful as the biometric ... ultimate driver in long-term mass consumer adoption of wearable ...
(Date:12/10/2014)... -- CIE San Diego has launched an innovative trust ... that enhances care coordination among social service and care ... earned a second $1 million grant from the Alliance ... in community and; will be recognized as a "Live ... 4-6p. CIE San Diego today announced the ...
Breaking Biology News(10 mins):New telemetry implants expected to change how large animal toxicology studies are conducted 2Wearable Technology Products Demand Highly Accurate Biometric Technology 2Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 2Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 3Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 4
Other Contents